Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.
about
The role of maintenance therapy in multiple myelomaPrevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis.The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.Lenalidomide: a review of its continuous use in patients with newly diagnosed multiple myeloma not eligible for stem-cell transplantation.An update in treatment options for multiple myeloma in nontransplant eligible patients.Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone.A systematic review of health-related quality of life in longitudinal studies of myeloma patients.Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.Health-related quality of life in patients with multiple myeloma--does it matter?Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent.Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
P2860
Q28071644-D331CD59-2E5B-4F1D-B040-28E3B2605C9BQ30248483-798B7C13-C720-4D05-A733-B71B934D6D14Q36069700-9F833C5C-5EF3-4246-A059-BD32A912DEACQ38450335-54F71D6D-FAA1-49E2-898D-E2234B2D07B4Q38561373-9D84B459-B583-4E71-A63E-D69B3E5FF4CDQ38713479-9DE106F6-8354-481A-8975-F148713AF8AFQ38742505-7A1D96FC-1FDB-483E-B18D-DFAB508EC191Q38818674-6334A8C4-D763-4A00-BDAA-144C65395A04Q38819936-1CD46672-6636-4684-BF5F-C2C5A172002EQ42848332-B9490656-BE2D-4A19-9968-961B35B323E3Q47552083-58EE43A8-F9EE-4C03-B50B-B63D9D7C4230Q48056468-A356BB5F-B31A-461F-8385-5F31436AA078
P2860
Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Health-related quality-of-life ...... alan, prednisone, thalidomide.
@ast
Health-related quality-of-life ...... alan, prednisone, thalidomide.
@en
type
label
Health-related quality-of-life ...... alan, prednisone, thalidomide.
@ast
Health-related quality-of-life ...... alan, prednisone, thalidomide.
@en
prefLabel
Health-related quality-of-life ...... alan, prednisone, thalidomide.
@ast
Health-related quality-of-life ...... alan, prednisone, thalidomide.
@en
P2093
P2860
P921
P1433
P1476
Health-related quality-of-life ...... alan, prednisone, thalidomide.
@en
P2093
Alberto Fragasso
Annette Ervin-Haynes
Bernard Lemieux
Bertrand Arnulf
Charles Zarnitsky
Christian Langer
Dan T Vogl
Jean-Claude Eisenmann
Kevin Song
Leonard Minuk
P2860
P304
P356
10.3324/HAEMATOL.2014.120121
P577
2015-03-13T00:00:00Z